MGC Pharmaceuticals Shares Rise on Facilities Upgrade, Strong Demand
marketwatch.com
news
2022-10-20 08:22:00

Shares in MGC Pharmaceuticals Ltd. rose Thursday after the company said that it has completed a processing upgrade to its Slovenian facility to increase daily production capacity by 200%. Shares at 0820 GMT were up 0.1 pence, or 14%, at 0.83 pence. The London and Australia-listed biopharma company said that the EU Good Manufacturing Practice, or GMP, audit for the facility was completed in October, which included approval to restart production. The company also said that it fast-tracked production to deliver 50,000 units of its ArtemiC Rescue product for AMC Holdings as AMC has experienced higher-than-expected demand.
